335 results on '"Rosen, Stuart D."'
Search Results
2. Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score
3. Cancer therapy related cardiac dysfunction as a result of Panitumumab
4. Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer
5. Healthcare systems data in the context of clinical trials – A comparison of cardiovascular data from a clinical trial dataset with routinely collected data
6. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment: Including myocarditis and the new entity of non inflammatory left ventricular dysfunction
7. Iatrogenic heart failure
8. Late cardiotoxicity related to HER2-targeted cancer therapy
9. Resilience and health—Can we aspire to more than just bouncing back?
10. Erratum for: Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected Cardiotoxicity
11. The United Kingdom’s First Cardio-Oncology Service
12. Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer
13. Evolving cardiac biomarkers for immune checkpoint inhibitor related myocarditis in cancer patients
14. Cardiovascular health: an important component of cancer survivorship
15. Appreciating the links between heart failure and depression
16. Cardiovascular health‐related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ‐C30 questionnaire
17. Le cœur a ses raisons que la raison ne connaît point - Neurocardiology continues to advance
18. Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer
19. A cross-sectional imaging study to identify organs at risk of thermal injury during renal artery sympathetic denervation
20. Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
21. Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients
22. P24 LVEF measured with same day echocardiography and CMR in patients with suspected cardiotoxicity
23. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment
24. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association
25. Targeting the autonomic nervous system: Measuring autonomic function and novel devices for heart failure management
26. Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)
27. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society
28. Neuroimaging of Heart Pain
29. Insights into the Pathophysiology of Syndrome X Obtained Using Positron Emission Tomography (PET)
30. A CHALLENGING CASE OF A LARGE RIGHT HEART MASS COMPLICATED BY COMPLETE HEART BLOCK
31. LEFT VENTRICULAR EJECTION FRACTION MEASURED WITH SAME DAY 2D ECHOCARDIOGRAPHY AND CMR IN PATIENTS WITH SUSPECTED CARDIOTOXICITY
32. Functional Neuroimaging of Angina Pectoris
33. Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal
34. Alan Margeston Harris
35. The biophysics of renal sympathetic denervation using radiofrequency energy
36. Portable echocardiography: Is essential for the management of acutely ill patients
37. Differing autonomic responses to dobutamine stress in the presence and absence of myocardial ischaemia
38. Heart failure with preserved ejection fraction: the impact of stricter definitions
39. The central nervous system and heart failure
40. Incidence of Cardiotoxicity and Validation of the Heart Failure Association- International Cardio-Oncology Society risk stratification Tool in Patients Treated with Trastuzumab for HER2-Positive Early Breast Cancer.
41. Tilt testing remains a valuable asset
42. Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
43. Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: implications for pharmacologic stress testing in coronary artery disease
44. Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial
45. Trastuzumab induced cardiomyopathy: wider implications for cardio-oncology
46. Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction
47. Utility of overnight pulse oximetry and heart rate variability analysis to screen for sleep-disordered breathing in chronic heart failure
48. Abnormal regional left ventricular mechanics in treated hypertensive patients with ‘normal left ventricular function’
49. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C ardio‐ O ncology S tudy G roup of the H eart F ailure A ssociation of the E uropean S ociety of C ardiology in collaboration with the I nternational C ardio‐ O ncology S ociety
50. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.